Legal Preparation and Compliance Representation During Pharmaceutical Audits

BRACE Law Firm provides comprehensive legal counsel regarding regulatory inspections and compliance audits targeting pharmaceutical organizations and medical device companies.

Any regulatory enforcement action demands meticulous preparation by the audited entity. To mitigate the risk of unlawful or overreaching measures by enforcement agencies, understanding the procedural nuances of inspections and the statutory boundaries of investigative authorities is paramount.

Liaison with Regulatory Authorities During Compliance Audits: Legal Support

The operations of life sciences enterprises and medical device entities are overseen by numerous state authorities. Specifically, investigative audits and on-site inspections may be initiated by the Federal Antimonopoly Service (FAS), the Federal Service for Surveillance in Healthcare (Roszdravnadzor), the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), the Prosecutor General’s Office, and various law enforcement agencies.

Legal Advocacy in Licensing Control and State Oversight

Licensing control over the market circulation of medicines and medical devices holds a critical position within the healthcare regulatory framework. As a general rule, the scope of an unannounced on-site inspection under licensing control protocols encompasses the verification of facilities, buildings, structures, technical systems, equipment, and other operational assets intended for use by the applicant or licensee, as well as confirming that personnel meet mandatory statutory requirements.

The scope of federal state oversight in the drug circulation sector entails verifying compliance by market participants with the statutory criteria established by Federal Law No. 61-FZ "On the Circulation of Medicines," dated April 12, 2010. This enforcement mechanism targets preclinical trials, clinical trials, storage conditions, logistics and transportation, importation, dispensing, commercialization, clinical utilization, and decommissioning or destruction of medicinal products, alongside verifying that drugs in commercial circulation conform to mandatory quality metrics.

Legal Defense During Inspections: Managing Regulatory Requests and Documentation

Entities subject to an inspection are legally obligated to furnish the antimonopoly authority (and its officials) with necessary documents, clarifications, and data in both written and oral forms within the specified deadline upon receiving a reasoned demand. This mandate extends to proprietary data constituting commercial, official, or other legally protected secrets, including corporate acts, agreements, certificates, business correspondence, and other materials maintained in digital or electronic formats. Notably, FAS inspections targeting pharmaceutical companies for potential cartel agreements and anti-competitive practices are highly prevalent.

The Prosecutor's Office of the Russian Federation is endowed with broad statutory authority to oversee compliance with applicable laws, including specialized healthcare regulations and life sciences frameworks.

Scope of Legal Offerings for Regulatory Inspections and Appeals

1. Advising on all aspects and typologies of regulatory inspections and compliance audits;
2. Conducting a rigorous legal analysis regarding the validity and lawfulness of the grounds for initiating an inspection;
3. Reviewing documentation and materials requested by enforcement agencies to determine the justification of the request and the lawfulness of the regulatory demands;
4. Evaluating potential enforcement liabilities arising from audit findings and formulating strategic recommendations to mitigate exposure, secure exemptions, or reduce penalties;
5. Representing client interests and managing communications directly before inspecting authorities;
6. Assisting with administrative appeals to challenge decisions, actions, or omissions of regulatory bodies before superior authorities;
7. Litigating before commercial courts to overturn unlawful regulatory actions, contest arbitrary enforcement measures, and appeal wrongful liability determinations resulting from such audits.